{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T23:07:01Z","timestamp":1790723221066,"version":"4.1.0"},"reference-count":78,"publisher":"MDPI AG","issue":"12","license":[{"start":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T00:00:00Z","timestamp":1701216000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Brain Sciences"],"abstract":"<jats:p>Background: A wide range of medications may have a possible role in the development of male-factor infertility (MFI), including various antineoplastic agents, testosterone\/anabolic steroids, immunosuppressive drugs\/immunomodulators, glucocorticosteroids, non-steroidal anti-inflammatory drugs, opiates, antiandrogenic drugs\/5-alpha-reductase inhibitors, various antibiotics, antidepressants, antipsychotics, antiepileptic agents and others. We aimed at investigating this issue from a pharmacovigilance-based perspective. Methods: The Food and Drug Administration (FDA) Adverse Event Reporting System (FAERS) database was queried to identify the drugs associated the most with MFI individual reports. Only those drugs being associated with more than 10 MFI reports were considered for the disproportionality analysis. Proportional Reporting Ratios (PRRs) and their confidence intervals were computed for all the drugs identified in this way in January 2023. Secondary, \u2018unmasking\u2019, dataset analyses were carried out as well. Results: Out of the whole database, 955 MFI reports were identified, 408 (42.7%) of which were associated with 20 medications, which had more than 10 reports each. Within this group, finasteride, testosterone, valproate, diethylstilbestrol, mechloretamine, verapamil, lovastatin and nifedipine showed significant levels of actual disproportionate reporting. Out of these, and before unmasking, the highest PRR values were identified for finasteride, diethylstilbestrol and mechloretamine, respectively, with values of 16.0 (12.7\u201320.3), 14.3 (9.1\u201322.4) and 58.7 (36.3\u201395.9). Conclusions: A variety of several medications, a number of which were already supposed to be potentially linked with MFI based on the existing evidence, were associated with significant PRR levels for MFI in this analysis. A number of agents which were previously hypothesized to be associated with MFI were not represented in this analysis, suggesting that drug-induced MFI is likely under-reported to regulatory agencies. Reproductive medicine specialists should put more effort into the detection and reporting of these adverse drug reactions.<\/jats:p>","DOI":"10.3390\/brainsci13121652","type":"journal-article","created":{"date-parts":[[2023,11,29]],"date-time":"2023-11-29T03:48:24Z","timestamp":1701229704000},"page":"1652","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["The Possible Role of Prescribing Medications, Including Central Nervous System Drugs, in Contributing to Male-Factor Infertility (MFI): Assessment of the Food and Drug Administration (FDA) Pharmacovigilance Database"],"prefix":"10.3390","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-8504-391X","authenticated-orcid":false,"given":"Sara","family":"Baldini","sequence":"first","affiliation":[{"name":"ASST Sette Laghi\u2014Circolo e Fondazione Macchi Hospital, 21100 Varese, Italy"},{"name":"Division of Urology, School of Medicine, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Khattak","sequence":"additional","affiliation":[{"name":"King\u2019s College Hospital NHS Foundation Trust, London SE5 9RS, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Capogrosso","sequence":"additional","affiliation":[{"name":"ASST Sette Laghi\u2014Circolo e Fondazione Macchi Hospital, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Antonini","sequence":"additional","affiliation":[{"name":"ASST Sette Laghi\u2014Circolo e Fondazione Macchi Hospital, 21100 Varese, Italy"},{"name":"Antonini Urology, 00185 Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Deh\u00f2","sequence":"additional","affiliation":[{"name":"ASST Sette Laghi\u2014Circolo e Fondazione Macchi Hospital, 21100 Varese, Italy"},{"name":"Division of Urology, School of Medicine, University of Insubria, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Schifano","sequence":"additional","affiliation":[{"name":"Psychopharmacology, Drug Misuse and Novel Psychoactive Substances Research Unit, School of Life and Medical Sciences, University of Hertfordshire, Hatfield AL10 9AB, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4828-4316","authenticated-orcid":false,"given":"Nicol\u00f2","family":"Schifano","sequence":"additional","affiliation":[{"name":"ASST Sette Laghi\u2014Circolo e Fondazione Macchi Hospital, 21100 Varese, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,11,29]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","unstructured":"Mascarenhas, M.N., Flaxman, S.R., Boerma, T., Vanderpoel, S., and Stevens, G.A. (2012). National, regional, and global trends in infertility prevalence since 1990: A systematic analysis of 277 health surveys. PLoS Med., 9.","DOI":"10.1371\/journal.pmed.1001356"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Practice Committee of the American Society for Reproductive Medicine (2020). Definitions of infertility and recurrent pregnancy loss: A committee opinion. Fertil. Steril., 113, 533\u2013535.","DOI":"10.1016\/j.fertnstert.2019.11.025"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Harrison, J.E., Weber, S., Jakob, R., and Chute, C.G. (2021). ICD-11: An international classification of diseases for the twenty-first century. BMC Med. Inform. Decis. Mak., 21.","DOI":"10.1186\/s12911-021-01534-6"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/humupd\/dmx022","article-title":"Temporal trends in sperm count: A systematic review and meta-regression analysis","volume":"23","author":"Levine","year":"2017","journal-title":"Hum. Reprod. Update."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1046\/j.1365-2605.2000.00250.x","article-title":"The advantages of standardized evaluation of male infertility","volume":"23","author":"Pierik","year":"2000","journal-title":"Int. J. Androl."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1093\/humupd\/dmad002","article-title":"Reproductive ability in survivors of childhood, adolescent, and young adult Hodgkin lymphoma: A review","volume":"29","author":"Drechsel","year":"2023","journal-title":"Hum. Reprod. Update."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1177\/0018578718795271","article-title":"The Newly Available FAERS Public Dashboard: Implications for Health Care Professionals","volume":"54","author":"Kumar","year":"2019","journal-title":"Hosp. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s40263-016-0359-y","article-title":"A Decade of Gabapentinoid Misuse: An Analysis of the European Medicines Agency\u2019s \u2018Suspected Adverse Drug Reactions\u2019 Database","volume":"30","author":"Chiappini","year":"2016","journal-title":"CNS Drugs"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s40264-017-0564-8","article-title":"Muscular Adverse Drug Reactions Associated with Proton Pump Inhibitors: A Disproportionality Analysis Using the Italian National Network of Pharmacovigilance Database","volume":"40","author":"Convertino","year":"2017","journal-title":"Drug Saf."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1002\/pds.3529","article-title":"Assessing the extent and impact of the masking effect of disproportionality analyses on two spontaneous reporting systems databases","volume":"23","author":"Maignen","year":"2014","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","article-title":"A method for estimating the probability of adverse drug reactions","volume":"30","author":"Naranjo","year":"1981","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4103\/jphi.JPHI_81_17","article-title":"An assessment of reported adverse drug reactions in a Tertiary Care Hospital in South India: A retrospective cross-sectional study","volume":"7","author":"Gupta","year":"2017","journal-title":"Int. J. Pharm. Investig."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"6634","DOI":"10.1016\/j.vaccine.2015.09.027","article-title":"Spontaneous reports of vasculitis as an adverse event following immunization: A descriptive analysis across three international databases","volume":"34","author":"Felicetti","year":"2016","journal-title":"Vaccine"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/S0140-6736(16)00619-X","article-title":"Public health and international drug policy","volume":"387","author":"Csete","year":"2016","journal-title":"Lancet"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.therap.2020.02.022","article-title":"Uses of pharmacovigilance databases: An overview","volume":"75","author":"Bihan","year":"2020","journal-title":"Therapie"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1517\/14740338.6.6.713","article-title":"Database size and power to detect safety signals in pharmacovigilance","volume":"6","author":"Hammond","year":"2007","journal-title":"Expert. Opin. Drug Saf."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s40264-018-0647-1","article-title":"EudraVigilance Medicines Safety Database: Publicly Accessible Data for Research and Public Health Protection","volume":"41","author":"Postigo","year":"2018","journal-title":"Drug Saf."},{"key":"ref_18","doi-asserted-by":"crossref","unstructured":"Schifano, N., Capogrosso, P., Boeri, L., Fallara, G., Cakir, O.O., Castiglione, F., Alnajjar, H.M., Muneer, A., Deho\u2019, F., and Schifano, F. (2022). Medications mostly associated with priapism events: Assessment of the 2015\u20132020 Food and Drug Administration (FDA) pharmacovigilance database entries. Int. J. Impot. Res.","DOI":"10.1038\/s41443-022-00583-3"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.6061\/clinics\/2013(Sup01)03","article-title":"The epidemiology and etiology of azoospermia","volume":"68","author":"Cocuzza","year":"2013","journal-title":"Clinics"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1007\/978-3-030-89340-8_9","article-title":"Oxidative Stress and Idiopathic Male Infertility","volume":"1358","author":"Sengupta","year":"2022","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1007\/s10815-020-02037-5","article-title":"Lack of trusted diagnostic tools for undetermined male infertility","volume":"38","author":"Pandruvada","year":"2021","journal-title":"J. Assist. Reprod. Genet."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"296","DOI":"10.5534\/wjmh.190055","article-title":"Male Oxidative Stress Infertility (MOSI): Proposed Terminology and Clinical Practice Guidelines for Management of Idiopathic Male Infertility","volume":"37","author":"Agarwal","year":"2019","journal-title":"World J. Mens. Health"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5070\/D32311037240","article-title":"Sexual side effects of 5-\u03b1-reductase inhibitors finasteride and dutasteride: A comprehensive review","volume":"23","author":"Fertig","year":"2017","journal-title":"Dermatol. Online J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"530121","DOI":"10.1155\/2012\/530121","article-title":"The 5 alpha-reductase isozyme family: A review of basic biology and their role in human diseases","volume":"2012","author":"Azzouni","year":"2012","journal-title":"Adv. Urol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/jc.2006-2203","article-title":"The effect of 5alpha-reductase inhibition with dutasteride and finasteride on semen parameters and serum hormones in healthy men","volume":"92","author":"Amory","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1016\/S0022-5347(05)68270-5","article-title":"Chronic treatment with finasteride daily does not affect spermatogenesis or semen production in young men","volume":"162","author":"Overstreet","year":"1999","journal-title":"J. Urol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1016\/j.fertnstert.2013.07.2000","article-title":"Finasteride use in the male infertility population: Effects on semen and hormone parameters","volume":"100","author":"Samplaski","year":"2013","journal-title":"Fertil. Steril."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"849.e17","DOI":"10.1016\/j.fertnstert.2007.08.026","article-title":"Propecia-induced spermatogenic failure: A report of two cases","volume":"90","author":"Liu","year":"2008","journal-title":"Fertil. Steril."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"1786.e9","DOI":"10.1016\/j.fertnstert.2010.12.001","article-title":"Finasteride-associated male infertility","volume":"95","author":"Chiba","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"2125.e13","DOI":"10.1016\/j.fertnstert.2010.12.061","article-title":"Finasteride-induced secondary infertility associated with sperm DNA damage","volume":"95","author":"Tu","year":"2011","journal-title":"Fertil. Steril."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11255-012-0315-9","article-title":"Secondary infertility due to use of low-dose finasteride","volume":"45","year":"2013","journal-title":"Int. Urol. Nephrol."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/s41443-022-00568-2","article-title":"Are finasteride-related penile curvature\/Peyronie\u2019s disease Adverse Event Reports worthy of further clinical investigation? Disproportionality analysis based on both the Food and Drug Administration (FDA) and the European Medicines Agency (EMA) pharmacov","volume":"35","author":"Schifano","year":"2022","journal-title":"Int. J. Impot. Res."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1016\/j.fertnstert.2012.03.025","article-title":"Morphometric-stereological and functional epididymal alterations and a decrease in fertility in rats treated with finasteride and after a 30-day post-treatment recovery period","volume":"97","author":"Garcia","year":"2012","journal-title":"Fertil. Steril."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.fertnstert.2019.11.030","article-title":"Post-finasteride syndrome: A surmountable challenge for clinicians","volume":"113","author":"Traish","year":"2020","journal-title":"Fertil. Steril."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1177\/0018578719882323","article-title":"Existence of Notoriety Bias in FDA Adverse Event Reporting System Database and Its Impact on Signal Strength","volume":"56","author":"Neha","year":"2021","journal-title":"Hosp. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.juro.2018.03.115","article-title":"Evaluation and Management of Testosterone Deficiency: AUA Guideline","volume":"200","author":"Mulhall","year":"2018","journal-title":"J. Urol."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0303-7207(01)00562-7","article-title":"Endocrine regulation of testicular function in men: Implications for contraceptive development","volume":"182","author":"Amory","year":"2001","journal-title":"Mol. Cell Endocrinol."},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"(1996). Contraceptive efficacy of testosterone-induced azoospermia and oligozoospermia in normal men. Fertil. Steril., 65, 821\u2013829.","DOI":"10.1016\/S0015-0282(16)58221-1"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"43","DOI":"10.23736\/S0031-0808.22.04677-8","article-title":"Impact of anabolic androgenic steroids on male sexual and reproductive function: A systematic review","volume":"65","author":"Esposito","year":"2023","journal-title":"Panminerva Med."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s40279-017-0709-z","article-title":"Effects of Anabolic Androgenic Steroids on the Reproductive System of Athletes and Recreational Users: A Systematic Review and Meta-Analysis","volume":"47","author":"Christou","year":"2017","journal-title":"Sports Med."},{"key":"ref_42","doi-asserted-by":"crossref","unstructured":"Schifano, N., Chiappini, S., Mosca, A., Miuli, A., Santovito, M.C., Pettorruso, M., Capogrosso, P., Deh\u00f2, F., Martinotti, G., and Schifano, F. (2022). Recreational Drug Misuse and Its Potential Contribution to Male Fertility Levels\u2019 Decline: A Narrative Review. Brain Sci., 12.","DOI":"10.3390\/brainsci12111582"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/FPC.0b013e32835ea0b2","article-title":"Valproic acid pathway: Pharmacokinetics and pharmacodynamics","volume":"23","author":"Thorn","year":"2013","journal-title":"Pharmacogenet Genom."},{"key":"ref_44","doi-asserted-by":"crossref","unstructured":"Mishra, M.K., Kukal, S., Paul, P.R., Bora, S., Singh, A., Kukreti, S., Saso, L., Muthusamy, K., Hasija, Y., and Kukreti, R. (2021). Insights into Structural Modifications of Valproic Acid and Their Pharmacological Profile. Molecules, 27.","DOI":"10.3390\/molecules27010104"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1046\/j.1468-1331.2003.00615.x","article-title":"Alterations in semen parameters in men with epilepsy treated with valproate or carbamazepine monotherapy","volume":"10","author":"Haugen","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Guo, Y., Chen, L., Wu, D., Yu, L., Sun, H., and Zhu, Q. (2021). A Comparative Study of the Effects of Valproate and Oxcarbazepine on Sexual Function, Sperm Quality, and Sex Hormones in Males with Epilepsy. Biomed. Res. Int., 2021.","DOI":"10.1155\/2021\/6624101"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"100446","DOI":"10.1016\/j.ebr.2021.100446","article-title":"Reversible male infertility with valproate use: A review of the literature","volume":"16","author":"Tallon","year":"2021","journal-title":"Epilepsy Behav. Rep."},{"key":"ref_48","first-page":"110","article-title":"Effects of antiepileptic drugs carbamazepine and sodium valproate on fertility of male rats","volume":"106","author":"Soliman","year":"1999","journal-title":"Dtsch. Tierarztl. Wochenschr."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1212\/WNL.57.3.440","article-title":"Early hormonal changes during valproate or carbamazepine treatment: A 3-month study","volume":"57","author":"Pakarinen","year":"2001","journal-title":"Neurology"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/0014-2999(90)90258-8","article-title":"Acute effects of anticonvulsant drugs on gonadotropin-stimulated and precursor-supported androgen production in the rat testis","volume":"181","author":"Herzog","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1177\/088307389100600102","article-title":"Carnitine, valproate, and toxicity","volume":"6","author":"Coulter","year":"1991","journal-title":"J. Child. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.jocn.2014.08.029","article-title":"Seminal fluid analysis and testicular volume in adults with epilepsy receiving valproate","volume":"22","author":"Hamed","year":"2015","journal-title":"J. Clin. Neurosci."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/humupd\/2.2.87","article-title":"Role of free L-carnitine and acetyl-L-carnitine in post-gonadal maturation of mammalian spermatozoa","volume":"2","author":"Jeulin","year":"1996","journal-title":"Hum. Reprod. Update"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1210\/jcem-43-6-1226","article-title":"The effects of diethylstilbestrol and medroxyprogesterone acetate on kinetics and production of testosterone and dihydrotestosterone in patients with prostatic carcinoma","volume":"43","author":"Nolten","year":"1976","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"ref_55","first-page":"52","article-title":"Effective testosterone suppression for prostate cancer: Is there a best castration therapy?","volume":"11","author":"Gomella","year":"2009","journal-title":"Rev. Urol."},{"key":"ref_56","first-page":"435","article-title":"Diethylstilbestrol exposure in utero: Review of literature","volume":"83","author":"Glaze","year":"1984","journal-title":"J. Am. Osteopath. Assoc."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1182\/blood.V4.4.338.338","article-title":"Nitrogen mustard therapy in Hodgkin\u2019s disease; analysis of 50 consecutive cases","volume":"4","author":"Dameshek","year":"1949","journal-title":"Blood."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ajh.24226","article-title":"Hodgkin lymphoma: MOPP chemotherapy to PD-1 blockade and beyond","volume":"91","author":"Ansell","year":"2016","journal-title":"Am. J. Hematol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1586\/17512433.2014.944500","article-title":"Mechlorethamine gel for the topical treatment of stage IA and IB mycosis fungoides-type cutaneous T-cell lymphoma","volume":"7","author":"Talpur","year":"2014","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1080\/14656566.2018.1491966","article-title":"Pharmacotherapy for generalized anxiety disorder in adult and pediatric patients: An evidence-based treatment review","volume":"19","author":"Strawn","year":"2018","journal-title":"Expert. Opin. Pharmacother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41585-022-00639-5","article-title":"Current and emerging treatment options for premature ejaculation","volume":"19","author":"Gul","year":"2022","journal-title":"Nat. Rev. Urol."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.fertnstert.2008.12.018","article-title":"Semen quality in fertile men in relation to psychosocial stress","volume":"93","author":"Gollenberg","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1016\/j.bmcl.2006.01.078","article-title":"The spermicidal and antitrichomonas activities of SSRI antidepressants","volume":"16","author":"Kumar","year":"2006","journal-title":"Bioorg Med. Chem. Lett."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"185.e5","DOI":"10.1016\/j.urology.2006.10.034","article-title":"Antidepressant-associated changes in semen parameters","volume":"69","author":"Tanrikut","year":"2007","journal-title":"Urology"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1017\/neu.2013.60","article-title":"Treatment with citalopram, but not with agomelatine, adversely affects sperm parameters: A case report and translational review","volume":"26","author":"Elnazer","year":"2014","journal-title":"Acta Neuropsychiatr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1016\/j.juro.2008.07.034","article-title":"Sperm DNA damage and semen quality impairment after treatment with selective serotonin reuptake inhibitors detected using semen analysis and sperm chromatin structure assay","volume":"180","author":"Safarinejad","year":"2008","journal-title":"J. Urol."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.fertnstert.2009.04.039","article-title":"Adverse effect of paroxetine on sperm","volume":"94","author":"Tanrikut","year":"2010","journal-title":"Fertil. Steril."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.urology.2022.01.026","article-title":"Selective Serotonin Reuptake Inhibitor (SSRI) Use is Not Associated With Impaired Semen Parameters","volume":"164","author":"Pham","year":"2022","journal-title":"Urology"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1474-8673.2010.00456.x","article-title":"Effects of long-term treatment with fluoxetine and venlafaxine on rat isolated vas deferens","volume":"30","author":"Utkan","year":"2010","journal-title":"Auton. Autacoid Pharmacol."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.phrs.2003.07.007","article-title":"Paroxetine alters KCl- or ATP-induced contractile responses of isolated vas deferens in rats chronically treated with ethanol","volume":"49","author":"Kesim","year":"2004","journal-title":"Pharmacol. Res."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"e13778","DOI":"10.1111\/and.13778","article-title":"Verapamil-induced ion channel and miRNA expression changes in rat testis and\/or spermatozoa may be associated with male infertility","volume":"52","author":"Tektemur","year":"2020","journal-title":"Andrologia"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0940-2993(00)80062-7","article-title":"Antireproductive effect of the calcium channel blocker amlodipine in male rats","volume":"52","author":"Almeida","year":"2000","journal-title":"Exp. Toxicol. Pathol."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S0015-0282(16)43348-0","article-title":"Sperm motility within the mammalian epididymis: Species variation and correlation with free calcium levels in epididymal plasma","volume":"29","author":"Morton","year":"1978","journal-title":"Fertil. Steril."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"613","DOI":"10.5114\/aoms.2011.24130","article-title":"Calcium antagonists modulate oxidative stress and acrosomal reaction in rat spermatozoa","volume":"7","author":"Morakinyo","year":"2011","journal-title":"Arch. Med. Sci."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Omolaoye, T.S., Halabi, M.O., Mubarak, M., Cyril, A.C., Duvuru, R., Radhakrishnan, R., and Du Plessis, S.S. (2022). Statins and Male Fertility: Is There a Cause for Concern?. Toxics, 10.","DOI":"10.3390\/toxics10100627"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1677\/jme.1.01515","article-title":"Nuclear oxysterol receptors, LXRs, are involved in the maintenance of mouse caput epididymidis structure and functions","volume":"33","author":"Frenoux","year":"2004","journal-title":"J. Mol. Endocrinol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/luts.12355","article-title":"Is medicinal ketamine associated with urinary dysfunction issues? Assessment of both the European Medicines Agency (EMA) and the UK Yellow Card Scheme pharmacovigilance database-related reports","volume":"13","author":"Schifano","year":"2021","journal-title":"LUTS Low. Urin. Tract. Symptoms"},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"59","DOI":"10.32725\/jab.2023.010","article-title":"Causality assessment of adverse drug reaction: A narrative review to find the most exhaustive and easy-to-use tool in post-authorization settings","volume":"21","author":"Pradhan","year":"2023","journal-title":"J. Appl. Biomed."}],"container-title":["Brain Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/12\/1652\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T21:33:08Z","timestamp":1760131988000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2076-3425\/13\/12\/1652"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,29]]},"references-count":78,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["brainsci13121652"],"URL":"https:\/\/doi.org\/10.3390\/brainsci13121652","relation":{},"ISSN":["2076-3425"],"issn-type":[{"value":"2076-3425","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,29]]}}}